;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Affimed sets IPO terms, raises series E

    Cancer immunotherapy company Affimed Therapeutics AG (Heidelberg, Germany) set the terms for a planned IPO on NASDAQ and also said it closed a EUR 11.7 million ($15.4 million) series E round. The company plans to sell 6…

    Published on 9/2/2014
  • FINANCIAL NEWS: Chiesi, Pappas launch rare disease-focused VC firm

    Chiesi Farmaceutici S.p.A. (Parma, Italy) and A. M. Pappas & Associates launched a new VC firm, Chiesi Ventures, to invest in early stage research on rare and orphan diseases. A. M. Pappas is an investor but said Chiesi…

    Published on 9/2/2014
  • FINANCIAL NEWS: Clearside raises $16 million B round

    Ophthalmic play Clearside Biomedical Inc. (Alpharetta, Ga.) raised $16 million in a series B round led by new investor RusnanoMedInvest. Existing investors Hatteras Venture Partners; Santen Pharmaceuticals Co. Ltd. (…

    Published on 9/2/2014
  • FINANCIAL NEWS: Clovis planning $200 million note deal

    Clovis Oncology Inc. (NASDAQ:CLVS) proposed late Tuesday to raise $200 million through the sale of senior convertible notes due 2021 in a private placement to institutional investors. Clovis' rucaparib (CO-338) is in …

    Published on 9/2/2014
  • FINANCIAL NEWS: Sofinnova Partners hires Richter as partner

    Sofinnova Partners hired Henrijette Richter as a partner. She was an investment director of Novo Seeds at Novo A/S. Sofinnova Partners has over EUR 1.3 billion ($1.7 billion) under management.

    Published on 9/2/2014
  • FINANCIAL NEWS: Tokai and Viking set IPO terms

    Tokai Pharmaceuticals Inc. (Cambridge, Mass.) and Viking Therapeutics Inc. (San Diego, Calif.) both set terms for planned IPOs on NASDAQ. Tokai plans to sell of 5.4 million shares at $13-$15. At $14, the company would …

    Published on 9/2/2014
  • FINANCIAL NEWS: Orexo raises $50.6 million

    Orexo AB (SSE:ORX; OTCQX:ORXOY) raised SEK346.5 million ($50.6 million) through the sale of 2.5 million shares at SEK139 in a private placement. The company sold 1.1 million treasury shares and issued 1.4 million new …

    Published on 8/29/2014
  • FINANCIAL NEWS: Titan proposes to raise up to $12 million

    Titan Pharmaceuticals Inc. (OTCBB:TTNP) proposed to raise up to $12 million through the sale of units in a follow-on underwritten by Roth Capital Partners. Each unit comprises a share and a warrant to purchase a share.…

    Published on 8/29/2014
  • FINANCIAL NEWS: Orexo raising private placement

    Orexo AB (SSE:ORX; OTCQX:ORXOY) is raising an undisclosed amount in a private placement with Swedish and international institutional and strategic investors. Danske Bank is the sole lead manager and bookrunner.Orexo …

    Published on 8/28/2014
  • FINANCIAL NEWS: Bellicum secures $55 million in series C

    Bellicum Pharmaceuticals Inc. (Houston, Texas) secured $55 million in a series C round from 11 new investors, including RA Capital; Perceptive Advisors; Jennison Associates; Sabby Capital; Ridgeback Capital Management; …

    Published on 8/27/2014
  • FINANCIAL NEWS: Capnia amends IPO

    Capnia Inc. (Redwood City, Calif.) amended its IPO on NASDAQ and now plans to raise $11.1 million through the sale of 1.7 million units at $6.50. Each unit comprises a share and a five-year warrant to purchase a share …

    Published on 8/27/2014
  • FINANCIAL NEWS: Dermatology play Dermira files for IPO

    Dermira Inc. (Redwood City, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Citigroup; Leerink; Guggenheim Securities; and Needham. Dermira said partner UCB Group (Euronext:UCB) may purchase…

    Published on 8/27/2014
  • FINANCIAL NEWS: Napo's Jaguar Animal Health files for IPO

    The Jaguar Animal Health Inc. subsidiary of Napo Pharmaceuticals Inc. (San Francisco, Calif.) filed to raise up to $70 million in an IPO on NASDAQ underwritten by BMO Capital Markets; Guggenheim Securities; and Roth …

    Published on 8/27/2014
  • FINANCIAL NEWS: Rhythm files for IPO

    Rhythm Pharmaceuticals Inc. (Boston, Mass.) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by Citigroup; Cowen; Canaccord Genuity; Oppenheimer; and Cantor Fitzgerald. Rhythm expects to begin a Phase…

    Published on 8/27/2014
  • FINANCIAL NEWS: Cancer play Calithera files for IPO

    Calithera Biosciences Inc. (South San Francisco, Calif.) filed to raise up to $80 million in an IPO on NASDAQ underwritten by Citigroup; Leerink Partners; Wells Fargo Securities; and JMP Securities. In February, …

    Published on 8/26/2014
  • FINANCIAL NEWS: Civitas files for IPO

    Civitas Therapeutics Inc. (Chelsea, Mass.) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by J.P. Morgan; BofA Merrill Lynch; Cowen; and Oppenheimer. Civitas plans to start Phase III testing of CVT-…

    Published on 8/26/2014
  • FINANCIAL NEWS: FortuneRock raises $23.6 million

    FortuneRock Ltd. (Beijing, China) raised RMB145 million ($23.6 million) in a venture round from international investors including Jinhua Pharmaceutical Co. Ltd. FortuneRock will use RMB120 million to spin out a company …

    Published on 8/26/2014
  • FINANCIAL NEWS: NeuroSigma files for IPO

    NeuroSigma Inc. (Los Angeles, Calif.) filed to raise up to $50 million in an IPO on NASDAQ underwritten by Jefferies; BTIG; and Craig-Hallum Capital Group. NeuroSigma markets its Monarch external trigeminal nerve …

    Published on 8/26/2014
  • FINANCIAL NEWS: Aldea closes $24 million B round

    Aldea Pharmaceuticals Inc. (Redwood City, Calif.) closed a $24 million series B round led by new investor RusnanoMedInvest. New investor WuXi PharmaTech Corporate Venture also participated, along with all of Aldea's …

    Published on 8/25/2014
  • FINANCIAL NEWS: Civitas secures $55 million in series C

    Civitas Therapeutics Inc. (Chelsea, Mass.) secured $55 million in a series C round from new investors Adage Capital Management; OrbiMed Advisors; Partner Fund Management; Rock Springs Capital; and Sofinnova Ventures. …

    Published on 8/25/2014
  • FINANCIAL NEWS: Median Technologies raising EUR 20 million

    Median Technologies Inc. (Euronext:ALMDT) plans to raise about EUR 20 million ($26.8 million) through the sale of 2.2 million units at EUR 9 in a private placement with institutional investors. Each unit comprises a …

    Published on 8/25/2014
  • FINANCIAL NEWS: AbbVie secures loans for Shire acquisition

    AbbVie Inc. (NYSE:ABBV) secured L3.2 billion ($5.4 billion) in a term loan and $4 billion in a revolving credit facility to help fund its acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG). AbbVie is buying Shire for about…

    Published on 8/22/2014
  • FINANCIAL NEWS: Bao Hao buying stake in 20/20 GeneSystems

    A U.S. affiliate of China's Bao Hao Investment Management Co. Ltd. will pay an undisclosed amount to acquire an equity stake in diagnostics company 20/20 GeneSystems Inc. (Rockville, Md.). 20/20 GeneSystems markets …

    Published on 8/22/2014
  • FINANCIAL NEWS: Ribomic planning Tokyo IPO

    Ribomic Inc. (Tokyo, Japan) is planning to raise Y2.7 billion ($26.3 million) through the sale of 1.2 million shares on the Tokyo Stock Exchange's Mothers in an IPO underwritten by Daiwa Securities and six other …

    Published on 8/22/2014
  • FINANCIAL NEWS: WaferGen raises $20M, moves to NASDAQ

    WaferGen Bio-systems Inc. (NASDAQ:WGBS) raised $20 million in a follow-on and moved its listing to NASDAQ from the over-the-counter market. Ladenburg Thalmann; National Securities; and Brean Capital were underwriters. …

    Published on 8/22/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993